encyclopedia jump navigation search prostate cancer name diagram position rectum oncology symptom difficulty blood urine pain pelvis back onset age risk factor family history race method tissue biopsy image diagnosis hyperplasia treatment surveillance surgery radiation therapy hormone chemotherapy survival rate frequency case death 
prostate cancer development gland system cell area body bone lymph node symptom stage difficulty blood urine pain pelvis back disease hyperplasia feel due level 
factor risk prostate cancer age family history disease race case male relative united  population diet meat milk product vegetable association gonorrhea reason relationship mutation biopsy image part body 
prostate cancer screen antigen  test detection outcome decision make year life expectancy 
inhibitor cancer risk prevention vitamin mineral 
case surveillance wait treatment combination surgery radiation therapy hormone chemotherapy prostate disease bone pain medication outcome person age health problem cancer men survival rate united  second type cause death  male country world detection area  test study content 
sign symptom risk factor genetics exposure infection diagnosis image biopsy tumor marker prevention diet  screen management surveillance cancer care classification system life expectancy epidemiology united  canada  history society culture research model reference link 
sign symptom diagram prostate cancer urethra 
prostate cancer symptom 
prostate cancer symptom disease hyperplasia 
urination night difficulty start stream urine blood 
study patient care evaluation prostate cancer symptom 
prostate cancer dysfunction gland urethra 
change gland function 
 deposit fluid urethra secretion prostate gland semen content cancer problem function performance difficulty erection ejaculation 
prostate cancer part body symptom 
symptom bone pain vertebrae spine pelvis rib 
spread cancer bone femur part 
prostate cancer spine cord leg weakness incontinence risk factor 
understand cause prostate cancer risk factor obesity age family history 
prostate cancer men age 
age time diagnosis men prostate cancer 
study men cause prostate cancer 
men family member prostate cancer risk disease brother father 
united  case prostate cancer death men blood pressure risk lack exercise genetics 
background prostate cancer risk association race family gene variant 
men father brother prostate cancer risk relative family history united  contrast incidence mortality rate white 
study twin  prostate cancer risk factor 
gene prostate cancer 
mutation  risk factor cancer breast  prostate gene hereditary receptor vitamin  family fusion cell growth rearrangement chain 
association study polymorphism prostate cancer risk 
example individual allele pair   time risk prostate cancer  
 part prostate cancer risk men descent  allele promoter region gene amount protein cell 
obesity blood level testosterone risk prostate cancer 
fruit vegetable benefit prostate cancer evidence role occurrence meat effect study consumption risk 
lower blood level vitamin risk prostate cancer 
acid supplement effect risk prostate cancer exposure 
link prostate cancer medication procedure condition use  risk infection 
infection inflammation prostate prostatitis chance cancer study blood flow area 
infection  syphilis risk 
virus study role prostate cancer evidence review  risk 
research war veteran agent orange risk prostate cancer recurrence surgery 
evidence cohort study ejaculation prostate cancer risk result trial benefit association vasectomy research relationship 
prostate part system make store fluid 
adult men prostate gram pelvis bladder front rectum 
prostate part urethra tube urine bladder urination semen ejaculation location disease defecation 
prostate gland fluid semen 
prostate cancer cell gland 
prostate gland hormone androgen work 
testosterone teste gland  prostate 
sex  hair muscle mass 
prostate cancer lymph node bone 
prostate cancer adenocarcinoma  gland cell 
region prostate gland adenocarcinoma zone 
clump cancer cell prostate gland condition carcinoma  neoplasia pin 
proof pin cancer precursor 
time cancer cell prostate tissue stroma tumor 
tumor organ vesicle rectum cell ability  system 
prostate cancer tumor mass cell area body 
invasion organ metastasis 
prostate cancer bone lymph node rectum bladder ureter progression 
route metastasis bone plexus prostate vein 
prostate  organ 
protein  transport zinc prostate cell 
role metabolism cell order citrate component semen 
process zinc accumulation alteration metabolism citrate production energy prostate cell amount  order task 
prostate cancer cell zinc 
prostate cancer cell energy citrate abundance 
absence zinc silence gene transporter protein 
tumor suppressor gene product 
cause silence 
strategy transport zinc prostate cell animal 
pathway  cell 
ingestion zinc concentration prostate cell transporter 
loss cancer suppressor gene carcinogenesis chromosome    
mutation prostate cancer set event pathology 
tumor suppressor gene role prostate cancer  
percent men prostate cancer copy gene time diagnosis frequency loss   
transcription factor cancer cell  development prostate 
 cascade growth factor prostate cancer cell survival protection  inhibitor  target research function proliferation  adhesion kinase pathway 
receptor prostate cancer cell target research study mouse membrane antigen development  level use increase  diagnosis  scan 
cancer position detection  test research benefit harm treatment 
cancer society men learn risk benefit test treatment 
age brother father condition talk doctor pro con test choice 
test information prostate tract 
examination doctor prostate abnormality 
tract bladder camera tube urethra 
 picture prostate sound wave probe rectum 
test diagnosis prostate cancer biopsy removal piece examination 
 resonance image  method prostate cancer detection 
use  prostate biopsy area tissue structure wave 
 tissue resolution 
prostate  tissue resolution  
 risk people surveillance stage disease bone 
 target prostate biopsy fusion  
men candidate surveillance fusion prostate biopsy cancer  
prostate  plan men prostatectomy 
surgeon bundle return continence help difficulty 
prostate  report system 
acronym  data system standard service resonance image creation report 
biopsy article needle prostate cancer adenocarcinoma invasion 
cancer biopsy 
biopsy urologist radiologist tissue sample prostate rectum 
biopsy gun insert  needle side prostate second 
biopsy outpatient basis hospitalization 
 complication fever tract infection sepsis course dose antibiotic percent men report discomfort prostate biopsy score article 
tissue sample microscope cancer cell feature score 
membrane antigen   hydrolase activity protein prostate cancer tissue  score marker 
tissue sample presence  tumor marker order origin cell 
cell carcinoma type prostate cancer  researcher way screen part body 
 development prostate cancer due level expression  stage pathology 
  ablation prostate carcinoma cell line rat model connection expression cancer progression 
expression   predictor patient outcome men prostate cancer article stage diagram 
part prostate cancer stage 
stage help prognosis therapy 
system  
component size tumor number lymph node presence  
distinction stage system cancer prostate 
system cancer prostate 
test evidence spread 
specialty organization use pet scan  bone physician stage prostate cancer risk metastasis test case spread pelvis look coil resonance image capsule vesicle 
bone scan appearance density area cancer 
prostate biopsy pathologist sample microscope 
cancer pathologist grade tumor 
grade tumor tissue prostate 
system grade prostate score abnormality 
pathologist number pattern microscope 
sum number score 
stage method 
sclerosis bone spine prostate cancer   image 
sclerosis bone spine prostate cancer   image 
sclerosis bone pelvis prostate cancer  
prevention diet  
data relationship diet prostate cancer light rate consumption evidence association  fat carbohydrate intake risk role acid research vitamin supplement effect calcium 
fish death occurrence evidence rate prostate cancer diet food lycopene selenium vegetable bean legume risk 
men exercise risk activity prostate cancer 
inhibitor risk prostate cancer data effect death chance case article screen 
prostate cancer screen effort symptom 
option exam antigen  blood test screen disruption consequence harm detection cancer benefit  approach consultation physician positive negative 
united  service task force decision  screen patient physician men year age male center disease control prevention conclusion society oncology college life expectancy person question risk benefit general test prostate cancer harm treatment 
urological association guideline benefit prostate cancer mortality man men period harm test treatment 
 offer screen decision make year kingdom program prostate cancer management article 
decision prostate cancer treatment 
prostate cancer form men treatment person health problem symptom 
 treatment surveillance prostate cancer management intent 
option stage disease score  level 
factor age health person view treatment side effect 
treatment side effect dysfunction incontinence discussion goal therapy risk  alteration 
combination treatment option prostate cancer 
guideline treatment situation estimation person life expectancy people questionnaire knowledge understand option 
treatment choice question radiotherapy surgery result outcome respect bowel function year 
radiation therapy prostatectomy option surgery quality life hand failure complication increase bladder colon cancer 
disease prostatectomy wait 
 effect position urination male prostate enlargement sit 
empty trend flow time surveillance 
men prostate cancer surveillance 
observation tumor time intention treatment sign cancer progression 
surveillance wait term treatment program monitor assumption palliative disease 
surveillance tumor sign growth appearance symptom 
monitor process  test examination prostate biopsy 
goal surveillance side effect treatment tumor people problem 
approach cancer anxiety people 
people prostate cancer harm person cause 
treatment prostate cancer surgery prostatectomy radiation therapy beam particle  chemotherapy chemotherapeutic drug combination 
use antigen  screen diagnosis age cancer stage majority case men year network guideline life expectancy treatment decision practice patient option radiation therapy wait pattern factor preference regard quality addition prostate risk pretreatment  score 
life expectancy advance treatment disease patient consequence prostate cancer 
interest role prostate cancer treatment modality surgery radiation population disease 
cancer prostate treatment option doctor use variety nomogram probability spread 
treatment surveillance beam radiation therapy  surgery general men cancer prostate 
therapy chemotherapy disease prostate 
exception therapy radiation treatment tumor amount  stage 
process tumor therapy chemotherapy treatment cancer 
cancer vaccine result benefit increase survival men prostate 
hormone cancer treatment year resume growth therapy 
prostate cancer  term  hormone castration treatment reduction  chemical mean reliance receptor activation 
cancer  treatment  survival benefit month chemotherapy combination   
treatment  increase survival month second line therapy placebo  agent advantage 
trial  chemotherapy 
subset people drug cell  stem desire outcome  claim dose combination therapy androgen agent 
advance combination block agent cell differentiation therapy drug care 
treatment prostate cancer surgery prostatectomy radiation therapy beam  chemotherapy chemotherapeutic drug combination 
prostate cancer rate country rest world 
risk factor prostate cancer country life expectancy diet meat 
access screen program detection rate 
united  prostate cancer time diagnosis survival rate  japan death   half people year men shanghai china  disease month 
patient treatment indicator disease outcome stage  level score 
general grade stage prognosis 
risk patient 
prediction experience group patient cancer stage 
  ablation therapy regression  prostate cancer  prize physiology medicine discovery 
ablation therapy remission  patient median survival month 
remission phenotype survival month time initiation ablation therapy prostate cancer progression possibility way change lack androgen patient 
classification system prostate adenocarcinoma type cancer 
needle biopsy 
prostate cancer men result disease 
decision treatment type time estimation risk tumor progress  mortality 
tool outcome stage recurrence surgery radiation therapy 
combine stage grade  level number percentage biopsy core age information 
classification men risk stage grade  
practice research set 
downside system parameter  score  patient 
table outcome margin status extension vesicle invasion variable 
 recurrence surgery radiation therapy data time diagnosis 
nomogram paper graph   computer 
score likelihood disease time interval treatment 
cancer risk assessment score status recurrence surgery 
accuracy nomogram paper table calculator 
point  grade stage age percentage core sum score double risk recurrence 
score data  
patient  search registry data veteran administration center cohort    university metastasis mortality radiation therapy wait deprivation 
life expectancy 
life expectancy projection average population  factor number 
example study man year life  men weight 
smoker year 
time evidence surgery beam radiation advantage regard death rate men form cancer 
information seed radiation life treatment data 
people disease prostate cancer year diagnosis 
men age disease survival year death cause 
men disease prostate cancer mortality year diagnosis age nature epidemiology death inhabitant data   
prostate cancer second cause death male rate world 
rate country south east   north   new  prostate cancer men figure 
incidence rate prostate cancer men united  time counterpart shanghai  detection china japan country 
men prostate cancer age majority case concern 
men prostate cancer identification condition treatment effect possibility live united  new case death male 
case  prostate cancer death united  
prostate cancer cause death men lung 
cancer  death 
incidence rate increase inception use antigen  screen fall 
decline prostate cancer incidence rate men year  
 mortality rate 
decline mortality rate jurisdiction benefit  screen observation phenomena treatment 
lifetime risk prostate cancer diagnosis disease 
cancer statistics society institute proportion disease stage white  
autopsy study men increase occult prostate cancer age year 
cancer men score indicator prostate canada 
prostate cancer type men 
 men prostate cancer  
 cancer breast case 
kingdom second cause cancer death lung case year die history 
prostate anatomist massa   cancer disease life expectancy detection method century 
treatment prostate cancer surgery obstruction removal gland prostatectomy   
young   hospital removal teste prostate cancer success 
resection prostate prostatectomy relief obstruction middle century function 
retropubic  walsh approach removal prostate lymph node maintenance function 
  
 study testosterone production men prostate cancer 
discovery castration   prize physiology medicine role hormone reproduction   
roger  prize physiology medicine work 
receptor agonist prostate cancer 
radiation therapy prostate cancer century radium implant 
beam radiotherapy  radiation source middle century 
seed prostate cancer 
chemotherapy prostate cancer 
regimen   host chemotherapy drug society culture 
people prostate cancer encounter disparity awareness fund media coverage treatment  prevalence guardian  nurse breast 
wait time referral diagnosis week breast cancer month prostate report 
prostate cancer coalition drug market treat breast 
time  cancer fund discrepancy kingdom government charity research  equality campaigner author warren  spend inequality example  health men 
area detection government fund mandate prostate cancer screen breast program 
example report state mandate insurance coverage routine breast cancer screen prostate experience media study coalition story cover 
prostate cancer awareness month place  number country 
ribbon cause research journal prostate cancer 
phase trial  patient population  approval   treatment prostate cancer 
phase trial patient bone metastasis 
analysis survival quality life 
study reason placebo group treatment 
bone isotope cancer cell alpha source 
food drug administration  schedule priority review program approval medicine agency 
inhibitor  promise trial     
medication block target  bind domain 
decade molecule domain therapy advantage prostate cancer  
 role survival prostate cancer cell target enzyme therapy tumor growth metastasis death  inhibitor 
prostate cancer progression profile study link signature model 
scientist prostate cancer cell line mechanism progression 
  prostate cancer cell line 
cancer cell line lymph node lesion adenocarcinoma 
cell adenocarcinoma bone brain 
cell receptor 
transcription factor receptor family 
development prostate signal cancer 
proliferation cell   
elevation expression prostate patient   cell deprivation study cancer progression 
 cell expression prostate antigen treatment 
paradox proliferation  prostate cancer cell 
virus prostate report find contamination journal science article diagnosis 
present area research investigation method prostate tumor detection 
test presence  fluid prostate urine sample investigation 
 prostate cell cancer 
test result specimen ratio   
replacement serum  level test tool men prostate cancer biopsy  
expression  sample likelihood biopsy presence cancer cell prostate 
prostate cancer foundation 
